Preschool Assessment of Preterm Infants Treated With Darbepoetin and Erythropoietin

CONCLUSIONS:
ESA-treated infants had better cognitive outcomes and less developmental impairment at 3.5 to 4 years of age compared with placebo-treated infants. ESAs show promise in improving long-term cognitive outcomes of infants born prematurely.

Source: PEDIATRICS - May 11, 2016 Category: Pediatrics Authors: Ohls, R. K., Cannon, D. C., Phillips, J., Caprihan, A., Patel, S., Winter, S., Steffen, M., Yeo, R. A., Campbell, R., Wiedmeier, S., Baker, S., Gonzales, S., Lowe, J. Tags: Developmental/Behavioral Pediatrics, Fetus/Newborn Infant, Neonatology Article Source Type: research